Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary
Compounding Law; Health Care; Awareness of all Types of Compounding Issues;
Pharmacy Benefit Managers (PBMs), Outsourcing Facilities
Food and Drug Administration and Compliance Issues
Wednesday, August 19, 2015
Drug-maker Amgen will pay out $71 million for making unsupported claims to promote off-label use of anemia drug Aranesp, and severe plaque psoriasis drug Enbrel, Time reports.
No comments:
Post a Comment